Improving Psychological Health Outcomes in Children with Atopic Dermatitis

Overview

Journal Clin Cosmet Investig Dermatol

Publisher Dove Medical Press

Specialty Dermatology

Date 2023 Oct 16

PMID 37841063

Authors

Niyaz Mostafa

Saxon D Smith

Affiliations

Soon will be listed here.

Abstract

Introduction: Atopic dermatitis (AD) is a chronic inflammatory skin disease that usually develops in early childhood. AD has a significant impact on quality of life and psychological health outcomes in both adults and children. There are increased reported rates of psychiatric comorbidities including anxiety, depression, ADHD and suicidal ideation compared to the general population. Primary caregivers of children with pediatric eczema and their families may also have derangements in psychological health and quality of life. A number of interventions exist for AD and address wellbeing outcomes as an important aspect of effective treatment.

Methods: A comprehensive literature search was conducted using PubMed/Medline, Embase, the Cochrane Central Register of Controlled Trials in February 2023. Published studies up to April 2023 were included related to interventions for childhood AD that included psychological health or quality of life outcomes. These interventions were stratified according to type and evidence quality.

Results: Search strategy revealed a wide variety of interventions with demonstrated improvements in quality of life or wellbeing of patients with pediatric AD or their families. Both pharmacological and non-pharmacological interventions demonstrated effectiveness in improving disease outcomes.

Conclusion: A variety of both pharmacological and non-pharmacological interventions may be employed to improve psychological health outcomes in children with AD.

References

Moore E, Williams A, Manias E, Varigos G . Nurse-led clinics reduce severity of childhood atopic eczema: a review of the literature. Br J Dermatol. 2006; 155(6):1242-8. DOI: 10.1111/j.1365-2133.2006.07534.x. View

JEKLER J, Larko O . UVB phototherapy of atopic dermatitis. Br J Dermatol. 1988; 119(6):697-705. DOI: 10.1111/j.1365-2133.1988.tb03490.x. View

OHare F, Molloy E . What is the best treatment for hyperkalaemia in a preterm infant?. Arch Dis Child. 2007; 93(2):174-6. DOI: 10.1136/adc.2007.127266. View

Seger E, Wechter T, Strowd L, Feldman S . Relative efficacy of systemic treatments for atopic dermatitis. J Am Acad Dermatol. 2018; 80(2):411-416.e4. DOI: 10.1016/j.jaad.2018.09.053. View

Siegfried E, Jaworski J, Kaiser J, Hebert A . Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis. BMC Pediatr. 2016; 16:75. PMC: 4895880. DOI: 10.1186/s12887-016-0607-9. View

Bakaa L, Pernica J, Couban R, Tackett K, Burkhart C, Leins L . Bleach baths for atopic dermatitis: A systematic review and meta-analysis including unpublished data, Bayesian interpretation, and GRADE. Ann Allergy Asthma Immunol. 2022; 128(6):660-668.e9. DOI: 10.1016/j.anai.2022.03.024. View

van Halewijn K, Lahnstein T, Bohnen A, van den Berg P, Pasmans S, Bindels P . Recommendations for emollients, bathing and topical corticosteroids for the treatment of atopic dermatitis: a systematic review of guidelines. Eur J Dermatol. 2022; 32(1):113-123. DOI: 10.1684/ejd.2022.4197. View

Kritsanaviparkporn C, Sangaphunchai P, Treesirichod A . Efficacy of moisturizers in paediatric atopic dermatitis: A systematic review and meta-analysis of randomised controlled trials. Indian J Dermatol Venereol Leprol. 2021; 88(1):22-31. DOI: 10.25259/IJDVL_1384_20. View

Schuttelaar M, Vermeulen K, Drukker N, Coenraads P . A randomized controlled trial in children with eczema: nurse practitioner vs. dermatologist. Br J Dermatol. 2009; 162(1):162-70. DOI: 10.1111/j.1365-2133.2009.09502.x. View

10.

Fuggle N, Bragoli W, Mahto A, Glover M, Martinez A, Kinsler V . The adverse effect profile of oral azathioprine in pediatric atopic dermatitis, and recommendations for monitoring. J Am Acad Dermatol. 2014; 72(1):108-14. PMC: 4274333. DOI: 10.1016/j.jaad.2014.08.048. View

11.

Papp K, Szepietowski J, Kircik L, Toth D, Eichenfield L, Leung D . Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies. J Am Acad Dermatol. 2021; 85(4):863-872. DOI: 10.1016/j.jaad.2021.04.085. View

12.

Musters A, Mashayekhi S, Harvey J, Axon E, Lax S, Flohr C . Phototherapy for atopic eczema. Cochrane Database Syst Rev. 2021; 10:CD013870. PMC: 8552896. DOI: 10.1002/14651858.CD013870.pub2. View

13.

Moore K, David T, Murray C, Child F, Arkwright P . Effect of childhood eczema and asthma on parental sleep and well-being: a prospective comparative study. Br J Dermatol. 2006; 154(3):514-8. DOI: 10.1111/j.1365-2133.2005.07082.x. View

14.

Yepes-Nunez J, Guyatt G, Gomez-Escobar L, Perez-Herrera L, Chu A, Ceccaci R . Allergen immunotherapy for atopic dermatitis: Systematic review and meta-analysis of benefits and harms. J Allergy Clin Immunol. 2022; 151(1):147-158. DOI: 10.1016/j.jaci.2022.09.020. View

15.

Zhao M, Liang Y, Shen C, Wang Y, Ma L, Ma X . Patient Education Programs in Pediatric Atopic Dermatitis: A Systematic Review of Randomized Controlled Trials and Meta-Analysis. Dermatol Ther (Heidelb). 2020; 10(3):449-464. PMC: 7211777. DOI: 10.1007/s13555-020-00365-z. View

16.

Schmitt J, Schmitt N, Meurer M . Cyclosporin in the treatment of patients with atopic eczema - a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2007; 21(5):606-19. DOI: 10.1111/j.1468-3083.2006.02023.x. View

17.

Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A . Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol Venereol. 2018; 32(6):850-878. DOI: 10.1111/jdv.14888. View

18.

Xie Q, Dai X, Tang X, Chan C, Chan C . Risk of Mental Disorders in Children and Adolescents With Atopic Dermatitis: A Systematic Review and Meta-Analysis. Front Psychol. 2019; 10:1773. PMC: 6691144. DOI: 10.3389/fpsyg.2019.01773. View

19.

Chow M, Morrow A, Robbins S, Leask J . Condition-specific quality of life questionnaires for caregivers of children with pediatric conditions: a systematic review. Qual Life Res. 2013; 22(8):2183-200. DOI: 10.1007/s11136-012-0343-z. View

20.

Dvorakova V, ORegan G, Irvine A . Methotrexate for Severe Childhood Atopic Dermatitis: Clinical Experience in a Tertiary Center. Pediatr Dermatol. 2017; 34(5):528-534. DOI: 10.1111/pde.13209. View